These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20574909)

  • 1. Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.
    Locke PA; Bruce Myers D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):376-84. PubMed ID: 20574909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of toxicity testing.
    Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals.
    Firestone M; Kavlock R; Zenick H; Kramer M;
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):139-62. PubMed ID: 20574895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century.
    Hartung T
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):277-90. PubMed ID: 20574902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME; Krewski D
    Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting the common needs of a more effective and efficient testing and assessment paradigm for chemical risk management.
    Dellarco V; Henry T; Sayre P; Seed J; Bradbury S
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):347-60. PubMed ID: 20574907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity testing in the 21st century: implications for human health risk assessment.
    Krewski D; Andersen ME; Mantus E; Zeise L
    Risk Anal; 2009 Apr; 29(4):474-9. PubMed ID: 19144067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 14. Exposure science and the U.S. EPA National Center for Computational Toxicology.
    Cohen Hubal EA; Richard AM; Shah I; Gallagher J; Kavlock R; Blancato J; Edwards SW
    J Expo Sci Environ Epidemiol; 2010 May; 20(3):231-6. PubMed ID: 18985077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions in toxicity testing.
    Krewski D; Westphal M; Al-Zoughool M; Croteau MC; Andersen ME
    Annu Rev Public Health; 2011; 32():161-78. PubMed ID: 21219154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Waddell WJ
    Hum Exp Toxicol; 2010 Jan; 29(1):31-2. PubMed ID: 20061465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncertainties for endocrine disrupters: our view on progress.
    Daston GP; Cook JC; Kavlock RJ
    Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priority screening of toxic chemicals and industry sectors in the U.S. toxics release inventory: a comparison of the life cycle impact-based and risk-based assessment tools developed by U.S. EPA.
    Lim SR; Lam CW; Schoenung JM
    J Environ Manage; 2011 Sep; 92(9):2235-40. PubMed ID: 21561706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically relevant exposure science for 21st century toxicity testing.
    Hubal EA
    Toxicol Sci; 2009 Oct; 111(2):226-32. PubMed ID: 19602574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.